MB
Manish Bhuleshwarnath Shukla
About Manish Bhuleshwarnath Shukla
Data last updated:
Manish Bhuleshwarnath Shukla is a Designated Partner at Gwala Fresh Llp (since 2018) and Director at Ophelia Pharmaceutical Private Limited (since 2017). The companies operate in Animal Husbandry and Pharma.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Gwala Fresh Llp AAM-4315 | Designated Partner | 16 Apr 2018 | 2018 | Active | |
 Ophelia Pharmaceutical Private Limited U24239MH2017PTC289242 | Director | 03 Jan 2017 | 2017 | Active |
Board colleagues of Manish Bhuleshwarnath Shukla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishi Pramod Khedwal | 05286631 | Gwala Fresh Llp | Designated Partner |
| Abhijeet Rajendra Chaube | 07594200 | Ophelia Pharmaceutical Private Limited | Director |
| Bipinkumar Hridaynarayan Pandey | 07594238 | Ophelia Pharmaceutical Private Limited | Director |
| Virendra Ramlal Pal | 07594284 | Ophelia Pharmaceutical Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Bhuleshwarnath Shukla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Bhuleshwarnath Shukla
Manish Bhuleshwarnath Shukla currently holds 2 directorships: Gwala Fresh Llp (Designated Partner, since 16 Apr 2018); Ophelia Pharmaceutical Private Limited (Director, since 03 Jan 2017).
Manish Bhuleshwarnath Shukla was first appointed on 03 Jan 2017 as Director at Ophelia Pharmaceutical Private Limited. The most recent appointment on record is 16 Apr 2018 at Gwala Fresh Llp.
The current boards of Manish Bhuleshwarnath Shukla's companies include Rishi Pramod Khedwal (Gwala Fresh Llp), Abhijeet Rajendra Chaube (Ophelia Pharmaceutical Private Limited), Bipinkumar Hridaynarayan Pandey (Ophelia Pharmaceutical Private Limited), Virendra Ramlal Pal (Ophelia Pharmaceutical Private Limited).